Patent ID: 9050342
Filing Date: 2015-06-09
Classification: A61K,A61P

Abstract:
1. A method of treating a disease in a mammal, wherein the disease is selected from the group consisting of atherosclerosis, myocardial infarction, hypercholesterolemia, hyperlipidemia, ischemic heart disease, congestive heart failure, acute coronary syndrome, plaque instability, coronary artery disease, cerebrovascular disease, peripheral vascular disease and cardiac risk management, comprising administering to a mammal in need thereof a therapeutically effective amount of a Janus Kinase inhibitor and a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof or a pharmaceutical composition of pharmaceutical composition comprising: a Janus Kinase inhibitor or a pharmaceutically acceptable salt thereof; and a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.